Wearable biosensor technology developer Biolinq announced today that it named Richard Yang as its new CEO.
San Diego-based Biolinq, which develops biosensor platforms to measure continuous glucose for managing diabetes, among other clinical conditions, said in a news release that Yang is a veteran of more than 20 years with time spent at top-tier medical device companies.
Get the full story on our sister site Drug Delivery Business News.